(Adnkronos) – SAN DIEGO and TOKYO and WETTEREN, Belgium, March 14, 2023 /PRNewswire/ — Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, received three CDMO
>>> vai all'articolo completo
